Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 21.44 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aerie Pharmaceuticals Inc | AERI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.40 | 1.9% | 21.44 | 21.78 | 20.8218 | 20.99 | 21.04 | 16:39:57 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 18.61 | 21.60 | 2.99 | 13.84% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,505 | 807,627 | $ 21.36 | $ 17,254,178 | 1,133,601 | 17.15 - 52.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:52:28 | 2 | $ 20.54 | USD |
Aerie Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 993.13M | 46.32M | $ -232.57M | -5.52 | - | 45.48M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 5.00 | 1.80% |
Aerie Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AERI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.59 | 21.78 | 18.44 | 19.95 | 1,020,757 | 2.85 | 15.33% |
| 1 Month | 19.01 | 21.78 | 17.15 | 19.02 | 827,720 | 2.43 | 12.78% |
| 3 Months | 23.85 | 24.82 | 17.15 | 20.19 | 1,204,478 | -2.41 | -10.1% |
| 6 Months | 35.25 | 35.74 | 17.15 | 22.05 | 1,096,142 | -13.81 | -39.18% |
| 1 Year | 39.68 | 52.00 | 17.15 | 29.00 | 855,241 | -18.24 | -45.97% |
| 3 Years | 36.40 | 74.75 | 17.15 | 41.86 | 588,254 | -14.96 | -41.1% |
| 5 Years | 30.96 | 74.75 | 8.8311 | 33.40 | 628,233 | -9.52 | -30.75% |
Aerie Pharmaceuticals Description
| Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America. |
